200 related articles for article (PubMed ID: 35480989)
1. A Bioinformatic Analysis: The Overexpression and Prognostic Potential of
Zhao Q; Zhang L; Wang Y; Sun Y; Wang T; Cao J; Qi M; Du X; Xia Z; Zhang R; Yang Y
Int J Gen Med; 2022; 15():4321-4337. PubMed ID: 35480989
[TBL] [Abstract][Full Text] [Related]
2. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analyses Reveal the Prognostic Value and Biological Roles of
Zhang L; Zhao Q; Mao L; Li H; Zhuang M; Wang J; Liu Y; Qi M; Du X; Xia Z; Sun N; Liu Q; Chen H; Zhang R
Int J Gen Med; 2021; 14():6059-6076. PubMed ID: 34594130
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Glutathione Peroxidases and Its Effect on Clinical Prognosis in Glioma Patients].
Ren XM; Zhang L; Xin B; Qian WW; Xia ZR; Qi M; DU XP; Shi CD; Liu QL; Zhang RQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):276-285. PubMed ID: 35538763
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1.
Hao J; He AY; Zhao X; Chen XQ; Liu QL; Sun N; Zhang RQ; Li PP
Cancer Control; 2023; 30():10732748231170485. PubMed ID: 37072373
[No Abstract] [Full Text] [Related]
7. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
8. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z
Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202
[TBL] [Abstract][Full Text] [Related]
10. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma.
Li P; Chen F; Yao C; Zhu K; Zhang B; Zheng Z
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741647
[TBL] [Abstract][Full Text] [Related]
11. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
12. DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway.
Su X; Liu J; Tu Z; Ji Q; Li J; Liu F
Transl Cancer Res; 2024 Apr; 13(4):1786-1806. PubMed ID: 38737693
[TBL] [Abstract][Full Text] [Related]
13. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
14. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
15. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
16. The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
Yao J; Chen X; Liu Z; Zhang R; Zhang C; Yang Q; Yao P; Jiang Q; Wu J; Zhao S
Chin Neurosurg J; 2021 Mar; 7(1):21. PubMed ID: 33750478
[TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas.
Li J; Wang J; Ding Y; Zhao J; Wang W
BMC Cancer; 2022 Apr; 22(1):466. PubMed ID: 35484511
[TBL] [Abstract][Full Text] [Related]
18. Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification.
Aili Y; Maimaitiming N; Maimaiti A; Liu W; Qin H; Ji W; Mahemuti Y; Wang Y; Wang Z
J Oncol; 2022; 2022():2621969. PubMed ID: 36504559
[TBL] [Abstract][Full Text] [Related]
19. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]